These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12016937)

  • 1. [Thrombolysis by staphylokinase in rabbits with experimental pulmonary embolus].
    Liu X; Tang Z; Liang X; Ma X; Chen W
    Yao Xue Xue Bao; 1998 Nov; 33(11):801-6. PubMed ID: 12016937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis.
    Lijnen HR; Stassen JM; Vanlinthout I; Fukao H; Okada K; Matsuo O; Collen D
    Thromb Haemost; 1991 Oct; 66(4):468-73. PubMed ID: 1796398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
    Li CJ; Huang J; Yang ZJ; Cao KJ
    Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models.
    Nagai N; Vanlinthout I; Collen D
    Circulation; 1999 Dec 21-28; 100(25):2541-6. PubMed ID: 10604893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant staphylokinase variants with altered immunoreactivity. II: Thrombolytic properties and antibody induction.
    Collen D; Moreau H; Stockx L; Vanderschueren S
    Circulation; 1996 Jul; 94(2):207-16. PubMed ID: 8674180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
    Vanderschueren S
    Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase.
    Vanwetswinkel S; Plaisance S; Zhi-Yong Z; Vanlinthout I; Brepoels K; Lasters I; Collen D; Jespers L
    Blood; 2000 Feb; 95(3):936-42. PubMed ID: 10648406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the immunogenicity of recombinant staphylokinase in patients and in animal models.
    Vanderschueren SM; Stassen JM; Collen D
    Thromb Haemost; 1994 Aug; 72(2):297-301. PubMed ID: 7831668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha.
    Moussa M; Ibrahim M; El Ghazaly M; Rohde J; Gnoth S; Anton A; Kensy F; Mueller F
    BMC Biotechnol; 2012 Dec; 12():96. PubMed ID: 23253823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy in pulmonary embolism.
    Goldhaber SZ; Bounameaux H
    Semin Vasc Med; 2001 Nov; 1(2):213-20. PubMed ID: 15199505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced thrombolysis induced by argatroban or activated protein C in the presence or absence of staphylokinase, measured in an in vivo animal model using mesenteric arterioles.
    Hashimoto M; Watanabe S; Oiwa K; Ohta Y; Kishi T; Okamoto T; Giddings JC; Yamamoto J
    Haemostasis; 2001; 31(2):80-9. PubMed ID: 11684863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic effects of recombinant staphylokinase on coronary thrombosis in miniature pigs].
    Li G; Fang XL; Ren Z; Li KQ; Zhou SH; Hu DQ; Wu GQ; Wang TL; Li WP
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jul; 36(4):369-374. PubMed ID: 33167101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung endothelium targeting for pulmonary embolism thrombolysis.
    Ding BS; Zhou YJ; Chen XY; Zhang J; Zhang PX; Sun ZY; Tan XY; Liu JN
    Circulation; 2003 Dec; 108(23):2892-8. PubMed ID: 14610017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Staphylokinase and its mutants: a new generation of thrombolytic agents].
    Lebrazi J; Elalamy I; Helft G; Samama MM
    J Mal Vasc; 1998 Apr; 23(2):92-8. PubMed ID: 9608920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris.
    Apte-Deshpnade A; Mandal G; Soorapaneni S; Prasad B; Kumar J; Padmanabhan S
    Biotechnol Lett; 2009 Jun; 31(6):811-7. PubMed ID: 19214390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of terrilytin in the treatment of experimental pulmonary vascular thrombosis].
    Kubatiev AA
    Biull Eksp Biol Med; 1979 Mar; 87(3):214-7. PubMed ID: 427272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.